 |
Fluorouracil |
|---|---|
| Trade Name | Adrucil |
| Orphan Indication | For use in combination with leucovorin for therapy of metastatic adenocarcinoma of the colon and rectum |
| USA Market Approval | USA |
| USA Designation Date | 1989-02-06 00:00:00 |
| Sponsor | Lederle Laboratories;Division of American Cyanamid Company, 401 N. Middletown Road;Pearl River, New York, 10965 |
